LL

Lasse Lehtinen

General Partner at Icebreaker.vc – we invest up to €1M in idea-stage startups in 🇪🇪, 🇫🇮 & 🇸🇪

Helsinki, Uusimaa

Invests in

Stages:

  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • General Partner

    2016

    Supporting +100 teams from Idea to Seed and beyond since 2017 We invest up to 1M€ first tickets in Estonia, Finland and Sweden. See our companies here: https://airtable.com/appQ5bZ5xXF33G2A5/shrSaCszlW1Z4UVfw/tblYEgViHK0mRBlE1

2017

  • Investor

    2022

  • Investor & Board Member

    2017 - 2022

    Icebreaker.vc was the first investor in HoxHunt. We made the initial investment in 1/2017 when the company was at idea / angel-stage: https://icebreaker.vc/news/hoxhunt Other investors: - First Fellow https://www.kauppalehti.fi/uutiset/siilasmaa-sijoitti-tietoturvatekoalyyn-kyberuhat-ovat-megaluokan-bisnesta/0464cf03-d535-3bb0-a6cc-59863bd89263) - €2.5M led by Dawn Capital https://icebreaker.vc/news/yay-our-portfolio-company-hoxhunt-closes-2-5m-round) - $40M Series-B round led by Level Equity https://sifted.eu/articles/cybersecurity-hoxhunt-raises-series-b/ This was a natural point for me to step off from the board as my focus is on supporting super early stage companies.

2024

  • Investor

    2024

2024

  • Investor

    2024

  • Investor & Board Member

    2021

    We acquire and grow brands that people love.

2022

  • Investor

    2022

    Leyr enables healthtech start-ups to succeed in the world of fragmented medical data. We offer our unified API platform as a simple and secure way to connect to multiple Electronic Medical Records in one go.

2021

  • Investor

    2021

    Solving the empty truck problem and saving 2.9 tons of CO2 for every 1000 pallets on the road

2023

  • Investor

    2023

    Easily store, manage and process your 3D point cloud data at scale

2021

  • Investor

    2021

    Liberating LatAm micro-entrepreneurs from bureaucracy

  • Investor

    2023

    On a mission to improve the lives of ADHD patients